When breathlessness isn’t just ageing: Campaign urges early action on pulmonary fibrosis

Persistent shortness of breath, a lingering dry cough, and an ever-present fatigue can be mistaken for the inevitabilities of aging. However, for some individuals, these could signify idiopathic pulmonary fibrosis (IPF), a relentless lung ailment where scar tissue builds up, rendering breathing more and more arduous. Despite its rarity, IPF is a testament to the fact that an estimated 3.6 million individuals globally are grappling with this relentless condition.

The symptoms of IPF often mimic common respiratory disorders or age-related transformations, leading to a diagnostic delay of up to two years. This delay can prove critical, as early intervention could have significantly altered the course of the disease. Symptoms can present uniquely in each patient, but a few common indicators include a consistent dry cough, breathlessness, exhaustion, and the fingers or toes developing a rounded, enlarged appearance—a condition known as clubbing.

Often, these changes in breathing are initially dismissed as the effects of aging, a lack of fitness, or simple fatigue. However, the Red Flags awareness campaign, spearheaded by Marjan Maghami, Medical Director of Boehringer Ingelheim for India, Middle East, Turkey, and Africa, aims to illuminate these early signs and encourage individuals to seek medical help sooner rather than later.

By providing clear and relatable information, the campaign seeks to empower people to recognize these symptoms early on and take proactive steps in their healthcare.

Early diagnosis of IPF plays a pivotal role in slowing the disease's progression and improving the patient's quality of life. With prompt medical attention, doctors can assess lung health more swiftly, establish a diagnosis faster, and initiate timely management strategies. While up to half of those diagnosed with IPF remain untreated, the campaign advocates for the adoption of 'green flags' in addition to the 'red flags' of early recognition.

These green flags include following treatment plans recommended by healthcare professionals, engaging in guided movement as advised by physicians, and managing symptoms to protect precious moments of life.

Despite the challenges posed by IPF, ongoing advancements in awareness, diagnosis, and treatment offer grounds for hope. Medical professionals are working diligently to bridge the gap between healthcare and the public, providing increased understanding of the disease, improved diagnostic tools, and effective treatments. Ultimately, the journey towards a healthier future requires collaboration from both sides: healthcare professionals and the individuals living with IPF.

By recognizing symptoms early and taking proactive steps to protect lung health, we can change the narrative for countless individuals affected by this relentless lung disease.